<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04276844</url>
  </required_header>
  <id_info>
    <org_study_id>2019/06</org_study_id>
    <nct_id>NCT04276844</nct_id>
  </id_info>
  <brief_title>Incidence of Postoperative Persistent Diaphragmatic Dysfunctions in Cardiac Surgery</brief_title>
  <acronym>INDYD</acronym>
  <official_title>Incidence of Postoperative Persistent Diaphragmatic Dysfunctions in Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative respiratory complication is a common complication that occurs in 6% of patients
      after cardiac surgery and increases morbidity and mortality and hospital length of stay.
      Diaphragmatic dysfunction (DD) is one of the main risk factors for post-operative respiratory
      distress syndrome. It alters the ventilatory mechanical function of patients and promotes
      pneumonia. In the literature, risk factors included older age, diabetes, harvesting of a
      mammary artery, intraoperative ice solution using, prolonged cardiopulmonary bypass and
      intra-operative phrenic nerve injury.

      Ultrasonography using the two-dimensional (2D) mode is a diagnosis tool for DD. For patients
      with DD, ultrasound criteria are: 1) an excursion during quiet breathing &lt; 9 mm for woman and
      &lt; 10 mm for man, 2) an excursion after sniff test &lt; 16 mm for woman and &lt; 18 mm for man and
      3) an excursion during deep breathing &lt; 37 mm for woman and &lt; 47 mm for man. A paradoxical
      diaphragmatic ascent may also be observed during inspiration.

      DD may be transient, linked to mechanical factors such as pain, the presence of pleural and
      mediastinal drains, lying down or sternotomy; with recovery from 5 postoperative days. It may
      be more prolonged (persistent after 7 days) in connection with a partial or complete phrenic
      nerve injury and / or diaphragmatic devascularization after mammary artery harvesting.

      The aim of this prospective study is to determine the incidence of persistent DD after
      cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diaphragmatic amplitude will be assessed by ultrasonography during quiet breathing and after
      sniff test, before the surgery and at day 7 post-surgery in all patients.

      Patients with persistent DD at day 7 post-surgery will have additional Respiratory Functional
      Explorations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of persistent diaphragmatic dysfunctions after cardiac surgery</measure>
    <time_frame>8 days</time_frame>
    <description>Diaphragmatic excursion measured during sniff test (displacement, mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of respiratory complications</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Occurrence of pneumonia, atelectasis requiring bronchial clearing by fibroscopy, reintubation, prolonged mechanical ventilation (&gt;24h) or prolonged non-invasive ventilation (&gt;48h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) length of stay</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Duration of ICU stay measured in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Duration of hospitalization measured in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory function test in the group with persistent diaphragmatic dysfunction</measure>
    <time_frame>8 days</time_frame>
    <description>Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV) and total lung capacity (TLC) measured at day 7 and compared to day 0</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Surgery, Cardiac</condition>
  <arm_group>
    <arm_group_label>Non diaphragmatic dysfunction at day 7 post-surgery</arm_group_label>
    <description>Diaphragmatic displacement after sniff test ≥ 16 mm for women and ≥ 18 mm for men</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Persistent diaphragmatic dysfunction at day 7 post-surgery</arm_group_label>
    <description>Diaphragmatic displacement after sniff test &lt; 16 mm for women and &lt; 18 mm for men</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasonography using the two-dimensional (2D) mode</intervention_name>
    <description>Diaphragmatic amplitude assessed by ultrasonography during quiet breathing and after sniff test, before the surgery and at day 7 post-surgery in all patients.</description>
    <arm_group_label>Non diaphragmatic dysfunction at day 7 post-surgery</arm_group_label>
    <arm_group_label>Persistent diaphragmatic dysfunction at day 7 post-surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Respiratory Functional Explorations</intervention_name>
    <description>Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV) and total lung capacity (TLC) measured at day 7</description>
    <arm_group_label>Persistent diaphragmatic dysfunction at day 7 post-surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        150 patients undergoing cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing cardiac surgery requiring sternotomy

          -  Consent for participation

          -  Affiliation to the social security system

        Exclusion Criteria:

          -  Contraindication to preoperative respiratory functional explorations

          -  Pregnant or breastfeeding women

          -  Patients under protection of the adults (guardianship, curators or safeguard of
             justice)

          -  Communication difficulties or neuropsychiatric disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe ESTAGNASIE, MD</last_name>
    <phone>(+33)1 46 41 89 71</phone>
    <email>philippe.estagnasie@wanadoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CMC Ambroise Paré</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <state>Ile-de-France</state>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Driss LAGHLAM, MD</last_name>
      <phone>(+33)1 46 41 89 71</phone>
      <email>driss.laghlam@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Driss LAGHLAM, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diaphragmatic paralysis</keyword>
  <keyword>Respiratory complications</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

